Pricing Log in Create free account

Matinas Biopharma Holdings, Inc. (MTNB) vs Atrinsic Inc. (PTIX)

Matinas Biopharma Holdings, Inc. and Atrinsic Inc. are both Biotechnology companies. Atrinsic Inc. is the larger, with a market value of $1.3M against $1.1M — 1.1× the size. Matinas Biopharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.2×. Across the 10 metrics below, Atrinsic Inc. leads on 7 and Matinas Biopharma Holdings, Inc. on 3.

Valuation

Metric MTNB PTIX Biotechnology median
P/E n/m 0.24 10.60
P/S 0.12 n/m 9.40
P/B 0.30 0.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.04 n/m 0.66
EV/Sales (0.06) n/m 9.02
Earnings yield (1,403.30%) 412.96% (32.88%)
Free cash flow yield (1,142.24%) (220.47%) (23.13%)

Profitability

Metric MTNB PTIX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (154.28%) (338.24%) (51.96%)
Return on assets (98.53%) 378.63% (46.06%)
Return on invested capital (419.27%) (229.86%) 0.00%

Growth

Metric MTNB PTIX Biotechnology median
Revenue growth (TTM) 2,135.91% — 6.76%
EPS growth (last fiscal year) 59.84% 188.24% 29.88%
Revenue growth, 5-year CAGR 55.69% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MTNB PTIX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.85 0.66 4.97
Net debt to EBITDA 0.62 0.52 1.01

Dividend

Metric MTNB PTIX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MTNB PTIX Biotechnology median
Market cap 1.14m 1.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack